New product

Anastrozole 1 mg 28 tabl





Active Ingredient:

Each capsule contains Anastozole 1 mg.

Inactive Ingredients:

Lactose monohydrate, Sodium starch glycolate, Povidone, Hypromellose, Polyethylene glycol, Titanium dioxide, Magnesium stearate.

Pharmacological Group:

Aromatase enzyme inhibitors..

Therapeutic Activity:

For the treatment of advanced breast cancer in post-menopausal women.

Side effects:

Severe skin reaction (Stevens-Johnson Syndrome) with bruises, ulcers or blisters; swelling of the face, lips, tongue and/or throat which may cause swallowing and/or breathing difficulties; headache, hot flushes, nausea, rash, joint stiffness or pain, arthritis, weakness, osteoporosis.


Should be stored in dry place below 25°C.


Teva Pharmaceutical Industries Ltd., Israel.

Registration Number of the Medicine in the National Drug registry of the Ministry of Health:

14132 31760 00/01

30 other products in the same category: